• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards: Medical Devices

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Part B: Supplementary Information Sheet (SIS)
FR Recognition List Number 036 Date of Entry 07/09/2014 
FR Recognition Number 19-10
Standard
UL  1642 5th Edition
Lithium Batteries
Scope/Abstract
1.1 These requirements cover primary (nonrechargeable) and secondary (rechargeable) lithium batteries for use as power sources in products. These batteries contain metallic lithium, or a lithium alloy, or a lithium ion, and may consist of a single electrochemical cell or two or more cells connected in series, parallel, or both, that convert chemical energy into electrical energy by an irreversible or reversible chemical reaction.

1.2 These requirements cover lithium batteries intended for use in technician-replaceable or user-replaceable applications.

1.3 These requirements are intended to reduce the risk of fire or explosion when lithium batteries are used in a product. The final acceptability of these batteries is dependent on their use in a complete product that complies with the requirements applicable to such product.

1.4 These requirements are also intended to reduce the risk of injury to persons due to fire or explosion when user-replaceable lithium batteries are removed from a product and discarded.

1.5 These requirements cover technician-replaceable lithium batteries that contain 5.0 g (0.18 oz) or less of metallic lithium. A battery containing more than 5.0 g (0.18 oz) of lithium is judged on the basis of compliance with the requirements in this standard, insofar as they are applicable, and further examination and test to determine whether the battery is acceptable for its intended uses.

1.6 These requirements cover user-replaceable lithium batteries that contain 4.0 g (0.13 oz) or less of metallic lithium with not more than 1.0 g (0.04 oz) of metallic lithium in each electrochemical cell. A battery containing more than 4.0 g (0.13 oz) or a cell containing more than 1.0 g (0.04 oz) lithium may require further examination and test to determine whether the cells or batteries are acceptable for their intended uses.

1.7 These requirements do not cover the toxicity risk that may result from the ingestion of a lithium battery or its contents, nor the risk of injury to persons that may occur if a battery is cut open to provide access to the metallic lithium.
Extent of Recognition
Complete standard
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
Relevant FDA Guidance and/or Supportive Publications*
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018.
FDA Technical Contacts
 Iacovos Kyprianou
  FDA/OC/CDRH/OSPTI/DAHRSSP/SSPI/
  301-796-2601
  iacovos.kyprianou@fda.hhs.gov
 Hamed Ghods
  FDA/OC/CDRH/OSEL/DBP/
  301-796-2656
  hamed.ghods@fda.hhs.gov
Standards Development Organization
UL Underwriters Laboratories, Inc. http://www.ul.com/
FDA Specialty Task Group (STG)
General II (ES/EMC)
*These are provided as examples and others may be applicable.
-
-